Neoantigen × AI
Daily research signal
TOPICS / MODALITY

TCR & T-cell receptor

T-cell-receptor biology and TCR-engineered cell therapy directed at tumor neoantigens — the readout side of antigen recognition.

Topic8 items2026-05-30 – 2026-06-03
01
AI / Methods

HLA micropolymorphisms confine neoantigen conformational adaptability and guide T cell receptor selectivity.

Research reveals that HLA micropolymorphisms confine neoantigen conformational adaptability, directly guiding T cell receptor selectivity. Specifically, micropolymorphisms in HLA-A*03:02 versus A*03:01 prevent TCR binding by altering the neoantigen's conformational ensemble rather than peptide binding, highlighting a critical mechanistic constraint for vaccine design that must be accounted for in antigen selection pipelines.

europepmc · brief 2026-06-03 · published 2026-06-01
02
AI / Methods

Healthy donor T cell receptors expand functional neoantigen recognition beyond patient vaccination - Science | AAAS

A Science publication reports that healthy donor T cell receptors can expand functional neoantigen recognition beyond patient vaccination. This finding suggests potential for off-the-shelf TCR therapies or broader immune monitoring strategies that do not rely solely on patient-specific vaccine responses.

news · brief 2026-06-02 · published 2026-04-17
05
AI / Methods

DapPep: Domain Adaptive Peptide-agnostic Learning for Universal T-cell Receptor-antigen Binding Affinity Prediction

Researchers introduced DapPep, a domain-adaptive peptide-agnostic learning framework for universal TCR-antigen binding affinity prediction. Using a lightweight self-attention architecture combined with protein language models, DapPep outperforms existing tools in predicting binding for unseen peptides, addressing a key bottleneck in neoantigen vaccine design for data-scarce settings.

arxiv · brief 2026-05-30 · published 2024-11-26
08
AI / Methods

Physicochemically Informed Dual-Conditioned Generative Model of T-Cell Receptor Variable Regions for Cellular Therapy

PhysicoGPTCR, a dual-conditioned generative protein Transformer, is introduced for designing TCR variable regions. Trained on TCR-peptide-HLA triples with physicochemical descriptors, the model improves binding-competent clone generation and sequence space exploration compared to baselines like GPTCR and VAEs, advancing computer-aided cellular therapy.

arxiv · brief 2026-05-30 · published 2025-10-07